Influence of ischemic preconditioning on blood coagulation, fibrinolytic activity and pancreatic repair in the course of caerulein-induced acute pancreatitis in rats

Journal of Physiology and Pharmacology

Volumn 58, Issue 2, 2007, Pages 303-319

  Warzecha, Z ^a   Dembiński, Artur ^a   Ceranowicz, P ^a   Dembinski M ^a   Cieszkowski, J ^a   Kusnierz Cabala B ^a   Naskalski, J W ^a   Jaworek, J ^a   Konturek, S J ^a   Pawlik, W W ^a   Tomaszewska, R ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Activated partial thromboplastin time; D dimer; Euglobulin clot lysis time; Interleukin 1 ; Pancreatic blood flow

Indexed keywords

CERULETIDE; D DIMER; DNA; INTERLEUKIN 10; INTERLEUKIN 1BETA; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; BLOOD CLOTTING; CELIAC ARTERY; CONTROLLED STUDY; DISEASE SEVERITY; DNA SYNTHESIS; EUGLOBULIN LYSIS TEST; FIBRINOLYSIS; HISTOLOGY; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; PANCREAS ACINUS; PANCREAS BLOOD FLOW; PARTIAL THROMBOPLASTIN TIME; PROTEIN BLOOD LEVEL; RAT; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ACUTE DISEASE; AMYLASES; ANIMALS; BLOOD COAGULATION; CAERULEIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; INTERLEUKIN-10; ISCHEMIC PRECONDITIONING; MALE; PANCREAS; PANCREATITIS; RATS; RATS, WISTAR;

EID: 34347368707     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bhatia M, Wong FL, Cao Y, et al. Pathophysiology of acute pancreatitis. Pancreatology 2005; 5: 132-144.
2. Gullo L, Cavicchi L, Tomassetti P, Spagnolo C, Freyrie A, D'Addato M. Effects of ischemia on the human pancreas. Gastroenterology 1996; 111: 1033-1038.
3. Klar E, Messmer K, Warshaw AL, Herfarth C. Pancreatic ischemia in experimental acute pancreatitis: mechanism, significance and therapy. Br J Surg 1990; 77: 1205-1210.
4. Lonardo A, Grisendi A, Bonilauri S, Rambaldi M, Selmi I, Tondelli E. Ischemic necrotizing pancreatitis after cardiac surgery. A case report and review of the literature. Ital J Gastroenterol Hepatol 1999; 31: 872-875.
5. Sakorafas GH, Tsiotos GG, Bower TC, Sarr MG. Ischemic necrotizing pancreatitis. Two case reports and review of literature. Int J Pancreatol 1998; 24: 117-121.
6. Warshaw AL, O'Hara PJ. Susceptibility of pancreas to ischemic injury in shock. Ann Surg 1978; 188: 197-201.
7. Fernandez-Cruz L, Sabater L, Gilberg R, Ricart MJ, Saens A, Astudillo E. Native and graft pancreatitis following combined pancreas-renal transplantation. Br J Surg 1993; 80: 1429-1432.
8. Waldner H. Vascular mechanism to induce acute pancreatitis. Eur Surg Res 1992; 24(suppl 1): 62-67.
9. Warzecha Z, Dembinski A, Ceranowicz P, et al. Protective effect of calcitonin gene-related peptide against caerulein-induced pancreatitis in rats. J Physiol Pharmacol 1997; 48: 775-787.
10. Warzecha Z, Dembinski A, Ceranowicz P, Stachura J, Tomaszewska R, Konturek SJ. Effect of sensory nerves and CGRP on the development of caerulein-induced pancreatitis and pancreatic recovery. J Physiol Pharmacol 2001; 52: 679-704.
11. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
12. Kato H, Liu Y, Kogure K, Kato K. Induction of 27-kDa heat shock protein following cerebral ischemia in a rat model of ischemic tolerance. Brain Res 1994; 634: 235-244.
13. Kume M. Yamamoto Y, Saad S, et al. Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996; 128: 251-258.
14. Mounsey RA, Pang CY, Boyd JB, Forrest C. Augmentation of skeletal muscle survival in the latissimus dorsi porcine model using acute ischemic preconditioning. J Otolaryngol 1992; 21: 315-320.
15. Dembinski A, Warzecha Z, Ceranowicz P, et al. Ischemic preconditioning reduces the severity of ischemia/reperfusion-induced pancreatitis. Eur J Pharmacol 2003; 473: 207-216.
16. Warzecha Z, Dembinski A, Ceranowicz P, et al. Ischemic preconditioning inhibits development of edematous cerulein-induced pancreatitis: Involvement of cyclooxygenases and heat shock protein 70. World J Gastroenterol 2005; 11: 5958-5965.
17. Lasson A, Ohlsson K. Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis. Thromb Res 1986; 41: 167-83.
18. Salomone T, Tosi P, Palareti G, et al. Coagulative disorders in human acute pancreatitis: role for the D-dimer. Pancreas 2003; 26: 111-116.
19. Agarwal N, Pitchumoni CS. Acute pancreatitis: a multisystem disease. Gastroenterologist 1993; 1: 115-128.
20. Esmon CT, Taylor FB Jr, Snow TR. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991; 66: 160-165.
21. Esmon CT. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. Baillieres Best Pract Res Clin Haematol 1999; 12: 343-359.
22. Konturek SJ, Szlachcic A, Dembinski A, Warzecha Z, Jaworek J, Stachura J. Nitric oxide in pancreatic secretion and hormone-induced pancreatitis in rats. Int J Pancreatol 1994; 15: 19-28.
23. Dembinski A, Warzecha Z, Ceranowicz P, et al. Variable effect of ghrelin administration on pancreatic development in young rats. Role of insulin-like growth factor-1. J Physiol Pharmacol 2005; 56: 555-570.
24. Warzecha Z, Dembinski A, Ceranowicz P, et al. Immunohistochemical expression of FGF-2, PDGF-A, VEGF and TGFβ RII in the pancreas in the course of ischemia/reperfusion-induced acute pancreatitis. J Physiol Pharmacol 2004; 55: 791-810.
25. Gallimore MJ, Tyler HM, Shaw JT. The measurement of fibrinolysis in the rat. Thromb Diath Haemorrh 1971; 26: 295-310.
26. Hata T, Kawataba A, Itoh E. Blood coagulation and fibrinolysis in SART-stressed (repeated cold-stressed) rats and drug effects on the altered hemostatic parameters. Jpn J Pharmacol 1991; 56: 403-412.
27. Dembiński A, Jaworek J, Konturek PK, Konturek SJ, Warzecha Z. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas. J Physiol 1989; 411: 419-435.
28. Dembiński A, Warzecha Z, Ceranowicz P, et al. Effect of ischemic preconditioning on pancreatic regeneration and pancreatic expression of vascular endothelial growth factor and platelet-derived growth factor-A in ischemia/reperfusion-induced pancreatitis. J Physiol Pharmacol 2006; 57: 39-58.
29. Frossard JL, Pastor CM. Experimental acute pancreatitis: new insight into the pathophysiology. Front Biosci 2002; 7: d275-d287.
30. Norman JG, Fink GW, Denham W, et al. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci 1997; 42: 1783-1788.
31. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1625-1652.
32. Moore KW, O'Garra A, de Waal MR, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165-190.
33. Van Laethem JL, Marchant A, Delvaux A, et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995; 108: 1917-1922.
34. Deviere J, Le Moine O, Van Laethem JL, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120: 498-505.
35. Dembinski A, Warzecha Z, Konturek PC, et al. Adaptation of pancreas to repeated caerulein-induced pancreatitis in rats. J Physiol Pharmacol 1996; 47: 455-467.
36. Warzecha Z, Dembinski A, Ceranowicz P, et al. Inhibition of cyclooxygenase-2 reduces the protective effect of hepatocyte growth factor in experimental pancreatitis. Eur J Pharmacol 2004; 486: 107-119.
37. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990; 66: 913-931.
38. Li YJ, Xiao ZS, Peng CF, Deng HW. Calcitonin gene-related peptide-induced preconditioning protects against ischemia-reperfusion injury in isolated rat hearts. Eur J Pharmacol 1996; 311: 163-167.
39. Fryer RM, Auchampach JA, Gross GJ. Therapeutic receptor targets of ischemic preconditioning. Cardiovasc Res 2002; 55; 520-525.
40. Ucar G, Topaloglu E, Burak Kandilci H, Gumusel B. Elevated semicarbazide-sensitive amine oxidase (SSAO) activity in lung with ischemia-reperfusion injury: protective effect of ischemic preconditioning plus SSAO inhibition. Life Sci 2005; 78: 421-427.
41. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 2004; 104: 3631-3634.
42. Tripodi A, Mannucci PM. Markers of activated coagulation and their usefulness in the clinical laboratory. Clin Chem 1996; 42: 664-669.
43. Halangk W, Matthias R, Schild L, Meyer F, Schultz HU, Lippert H. Effect of supramaximal cerulein stimulation on mitochondrial energy metabolism in rat pancreas. Pancreas 1998; 16: 88-95.
44. Konturek SJ, Dembiński A, Konturek PJ, et al. Role of platelet activating factor In the pathogenesis of acute pancreatitis in rats. Gut 1992; 33: 1268-1274.
45. Jaworek J, Jachimczak B, Tomaszewska R, et al. Protective action of lipopolysaccharides in rat caerulein-induced pancreatitis: role of nitric oxide. Digestion 2000; 62: 1-13.
46. Dembinski A, Warzecha Z, Konturek SJ, et al. Extract of grapefruit-seed reduces acute pancreatitis induced by ischemia/reperfusion in rats: possible implication of tissue antioxidants. J Physiol Pharmacol 2004; 55: 811-821.
47. Warzecha Z, Dembinski A, Jaworek J, et al. Role of sensory nerves in pancreatic secretion and caerulein-induced pancreatitis. J Physiol Pharmacol 1997; 48: 43-58.